Business Description
Shanghai Yizhong Pharmaceutical Co Ltd
ISIN : CNE1000050F4
Compare
Compare
Traded in other countries / regions
688091.China IPO Date
2021-09-09Description
Shanghai Yizhong Pharmaceutical Co Ltd is a pharmaceutical enterprise integrating research and development, production and sales. It is committed towards the development of new dosage forms of anti-tumor drugs and related products.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.96 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 95.98 | |||||
| Beneish M-Score | -0.44 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | 55.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.25 | |||||
| 9-Day RSI | 33.19 | |||||
| 14-Day RSI | 35.37 | |||||
| 6-1 Month Momentum % | -28.68 | |||||
| 12-1 Month Momentum % | -4.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 24.53 | |||||
| Quick Ratio | 24.25 | |||||
| Cash Ratio | 20.52 | |||||
| Days Inventory | 240.43 | |||||
| Days Sales Outstanding | 58.96 | |||||
| Days Payable | 307.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.55 | |||||
| Dividend Payout Ratio | 0.31 | |||||
| Forward Dividend Yield % | 0.55 | |||||
| 5-Year Yield-on-Cost % | 0.52 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 0.41 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 93.06 | |||||
| Operating Margin % | 50.73 | |||||
| Net Margin % | 51.02 | |||||
| ROE % | 14.07 | |||||
| ROA % | 13.67 | |||||
| ROIC % | 57.79 | |||||
| ROC (Joel Greenblatt) % | 97.7 | |||||
| ROCE % | 15.88 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 46.09 | |||||
| PE Ratio without NRI | 46.09 | |||||
| PS Ratio | 23.53 | |||||
| PB Ratio | 6.35 | |||||
| Price-to-Tangible-Book | 6.58 | |||||
| Price-to-Free-Cash-Flow | 73.93 | |||||
| Price-to-Operating-Cash-Flow | 60.27 | |||||
| EV-to-EBIT | 36.78 | |||||
| EV-to-EBITDA | 36.78 | |||||
| EV-to-Revenue | 21.27 | |||||
| EV-to-FCF | 72.57 | |||||
| Price-to-Graham-Number | 3.66 | |||||
| Price-to-Net-Current-Asset-Value | 7.25 | |||||
| Price-to-Net-Cash | 8.76 | |||||
| Earnings Yield (Greenblatt) % | 2.72 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Yizhong Pharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 364.518 | ||
| EPS (TTM) (Â¥) | 1.215 | ||
| Beta | 0 | ||
| Volatility % | 37.66 | ||
| 14-Day RSI | 35.37 | ||
| 14-Day ATR (Â¥) | 2.258077 | ||
| 20-Day SMA (Â¥) | 57.949 | ||
| 12-1 Month Momentum % | -4.57 | ||
| 52-Week Range (Â¥) | 54 - 96.181818 | ||
| Shares Outstanding (Mil) | 158.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Yizhong Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Yizhong Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Yizhong Pharmaceutical Co Ltd Frequently Asked Questions
What is Shanghai Yizhong Pharmaceutical Co Ltd(SHSE:688091)'s stock price today?
The current price of SHSE:688091 is ¥56.30. The 52 week high of SHSE:688091 is ¥96.18 and 52 week low is ¥54.00.
When is next earnings date of Shanghai Yizhong Pharmaceutical Co Ltd(SHSE:688091)?
The next earnings date of Shanghai Yizhong Pharmaceutical Co Ltd(SHSE:688091) is .
Does Shanghai Yizhong Pharmaceutical Co Ltd(SHSE:688091) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Yizhong Pharmaceutical Co Ltd(SHSE:688091) is 0.55% (As of Today), Highest Dividend Payout Ratio of Shanghai Yizhong Pharmaceutical Co Ltd(SHSE:688091) was 0.31. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Shanghai Yizhong Pharmaceutical Co Ltd(SHSE:688091) is 0.55%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers